Efficacy and Safety of Intravenous Neridronic Acid in CRPS

NCT03530345 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

182

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Complex Regional Pain Syndrome (CRPS)

Interventions

DRUG: Neridronic acid 100 mg
DRUG: Placebo

Sponsor

Grünenthal GmbH